1Low TLK,Thurman GB, Mcadoo M, et al. The chemistry and Biology of thymosin[J] .J Bio chem, 1979,254:981-986.
2Hadziyanis S, Bramou T, Makris, et al. Interferon alpha-2b treatment of HBeAg negative/serum HBV DNA positive chroric active hepatitis type B[J]. J Hepatol, 1990,11 (suppl)133-136.
4Chan HL, Tang JL, Tam W, et al. The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: a meta-analysis. Aliment Pharmacol Ther, 2001, 15: 1899-1905.
5Saruc M, Ozden N, Turkel N, et al. Long-term outcomes of thymosin-alpha 1 and interferon alpha-2b combination therapy in patients with hepatitis B e antigen (HBeAg) negative chronic hepatitis B. J Pharm Sci, 2003, 92: 1386-1395.
6Lim SG, Wai CT, Lee YM, et al. A randomized, placebo-controlled trial of thymosin-alphal and lymphoblastoid interferon for HBeAg- positive chronic hepatitis B. Antiviral Ther, 2006, 11 : 245-253.
7Chien RN, Liaw YF. Thymalfasin for the treatment of chronic hepatitis B. Expert Rev Anti Infect Ther, 2004, 2: 9-16.
8Yang YF, Zhao W, Zhong YD, et al. Comparison of the efficacy of thymosin alpha- 1 and interferon alpha in the treatment of chronic hepatitis B: a meta-analysis. Antiviral Res, 2008, 77: 136-141.
